title: Mast cells in diffuse large B-cell lymphoma; their role in fibrosis.
abstract: OBJECTIVE
  Mast cells (MCs) are associated with fibrosis in various diseases. MCs comprise two phenotypes: the MC(TC) phenotype contains tryptase and chymase, whereas the MC(T) phenotype contains tryptase. Interleukin (IL)-4 promotes the development of MC(TC) from the MC(T) phenotype. The aim of this study was to determine the relationship between MC phenotypes and fibrosis in diffuse large B-cell lymphoma (DLBCL).
  
  
  RESULTS
  We examined the distribution and density of MCs in 50 DLBCL and 20 reactive lymph nodes, and evaluated MC phenotypes and IL-4-expressing cells. To detect MCs, immunohistochemistry for tryptase and chymase was performed. The 50 DLBCLs were histologically divided into three groups: no fibrosis (32 cases), reticular type (eight cases) showing reticular fibrosis, and bundle type (10 cases) showing collagenous bundles. The density of tryptase-positive MCs was higher than that of chymase-positive MCs. The densities of tryptase-positive and chymase-positive MCs in fibrotic areas were significantly higher than those in the cellular areas in the reticular and bundle groups. Double immunostaining revealed that MCs in DLBCL comprised MC(T) and MC(TC) phenotypes. Chymase-positive MCs and T lymphocytes expressed IL-4. Although there were few chymase-positive MCs in reactive lymph nodes, the density of tryptase-positive MCs was not different from that in the 'no fibrosis' group.
  
  
  CONCLUSIONS
  Tryptase-positive and chymase-positive MCs are associated with fibrosis in DLBCL.
authors.affiliation: Clinical Haematology and Diagnostics, Osaka City University, Graduate School of Medicine, Osaka, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Fukushima
authors.forename: M
authors.initials: M
authors.lastname: Ohsawa
authors.forename: Y
authors.initials: Y
authors.lastname: Ikura
authors.forename: T
authors.initials: T
authors.lastname: Naruko
authors.forename: Y
authors.initials: Y
authors.lastname: Sugama
authors.forename: T
authors.initials: T
authors.lastname: Suekane
authors.forename: C
authors.initials: C
authors.lastname: Kitabayashi
authors.forename: T
authors.initials: T
authors.lastname: Inoue
authors.forename: M
authors.initials: M
authors.lastname: Hino
authors.forename: M
authors.initials: M
authors.lastname: Ueda
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism; D053818:Chymases / Q000276:immunology / Q000378:metabolism; D005260:Female; D005355:Fibrosis / Q000201:enzymology / Q000473:pathology*; D006801:Humans; D007124:Immunoenzyme Techniques; D015847:Interleukin-4 / Q000378:metabolism; D008198:Lymph Nodes / Q000201:enzymology / Q000473:pathology; D016393:Lymphoma, B-Cell / Q000201:enzymology / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000201:enzymology / Q000473:pathology*; D008297:Male; D008407:Mast Cells / Q000201:enzymology / Q000473:pathology*; D008875:Middle Aged; D010641:Phenotype; D012189:Retrospective Studies; D053802:Tryptases / Q000276:immunology / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; C508598:IL4 protein, human; D015847:Interleukin-4; D053818:Chymases; D053802:Tryptases